Open Access. Powered by Scholars. Published by Universities.®
- Discipline
-
- Life Sciences (14)
- Pharmaceutical Preparations (14)
- Pharmacy and Pharmaceutical Sciences (11)
- Diseases (10)
- Other Pharmacy and Pharmaceutical Sciences (10)
-
- Medical Sciences (9)
- Analytical, Diagnostic and Therapeutic Techniques and Equipment (7)
- Cell and Developmental Biology (7)
- Amino Acids, Peptides, and Proteins (6)
- Cancer Biology (5)
- Nervous System Diseases (5)
- Therapeutics (5)
- Medical Neurobiology (4)
- Medicinal and Pharmaceutical Chemistry (4)
- Pharmaceutics and Drug Design (4)
- Animal Experimentation and Research (3)
- Biochemistry, Biophysics, and Structural Biology (3)
- Cell Biology (3)
- Medical Specialties (3)
- Molecular Biology (3)
- Pharmacology, Toxicology and Environmental Health (3)
- Physical Sciences and Mathematics (3)
- Research Methods in Life Sciences (3)
- Alternative and Complementary Medicine (2)
- Anatomy (2)
- Biochemistry (2)
- Biological Phenomena, Cell Phenomena, and Immunity (2)
- Institution
-
- Chapman University (10)
- City University of New York (CUNY) (3)
- James Madison University (3)
- Virginia Commonwealth University (3)
- University of New Mexico (2)
-
- Illinois Math and Science Academy (1)
- Louisiana State University (1)
- Portland State University (1)
- Rowan University (1)
- Seton Hall University (1)
- Southern Methodist University (1)
- Technological University Dublin (1)
- University of Nebraska at Omaha (1)
- University of North Dakota (1)
- University of Rhode Island (1)
- Wayne State University (1)
- West Virginia University (1)
- Keyword
-
- Alzheimer’s disease (2)
- Cystic fibrosis (2)
- Drug delivery (2)
- Erythropoietin (2)
- Transferrin receptor (2)
-
- Acetylation (1)
- Aerosols -- Health aspects (1)
- Aging (1)
- Airway smooth muscle (1)
- Antibacterial agent (1)
- Antibiotic (1)
- Antibiotic resistance (1)
- Antidepressants (1)
- Antipsychotics (1)
- Apoptosis (1)
- BETs (1)
- Binding affinity (1)
- Biocompatibility (1)
- Bioorthogonal (1)
- Blood analysis (1)
- Blood-brain barrier (1)
- Blood–brain barrier (1)
- Bone (1)
- Breast cancer (1)
- CSC inhibitors (1)
- Cannabis (1)
- Cell Biology (1)
- Cell cycle arrest (1)
- Cerebral amyloid angiopathy (1)
- Cerebral microhemorrhage (1)
- Publication
-
- Pharmacy Faculty Articles and Research (9)
- Theses and Dissertations (3)
- Dissertations, Theses, and Capstone Projects (2)
- Physician Assistant Capstones, 2016 to 2019 (2)
- Articles (1)
-
- Biological Sciences Theses and Dissertations (1)
- Biomedical Engineering ETDs (1)
- Chemistry Faculty Publications and Presentations (1)
- Clinical Research in Practice: The Journal of Team Hippocrates (1)
- Graduate Theses, Dissertations, and Problem Reports (ETD) (1)
- LSU Doctoral Dissertations (1)
- Library Articles and Research (1)
- Nanoscience and Microsystems ETDs (1)
- Physician Assistant Scholarly Project Papers (1)
- Rowan-Virtua Research Day (1)
- Senior Honors Projects (1)
- Senior Honors Projects, 2010-2019 (1)
- Seton Hall University Dissertations and Theses (ETDs) (1)
- Student Leadership Exchange (SLX) (1)
- Student Theses (1)
- UNO Student Research and Creative Activity Fair (1)
- Publication Type
- File Type
Articles 31 - 33 of 33
Full-Text Articles in Other Chemicals and Drugs
In Vitro Metabolism Of The Synthetic Cannabinoids Px-1, Px-2, Px-3 And A Comparison Of Their Clearance Rates In Human Liver Microsomes, Travon Cooman
In Vitro Metabolism Of The Synthetic Cannabinoids Px-1, Px-2, Px-3 And A Comparison Of Their Clearance Rates In Human Liver Microsomes, Travon Cooman
Graduate Theses, Dissertations, and Problem Reports (ETD)
Detection of SCs in body fluids continue to be a challenge because of limited metabolism data, lack of standards and reference mass spectrometry data. In vivo and in vitro experiments help elucidate metabolite markers for novel psychoactive substances and can prompt synthesis of standards to verify proposed metabolites. In this study, metabolism of three SCs N-(1-amino-1-oxo-3-phenylpropan-2-yl)-1-(5-fluoropentyl)-1H-indole-3-carboxamine (PX-1), N-(1-amino-1-oxo-3-phenylpropan-2-yl)-1-(5-fluropentyl)-1H-indazole-3-carboxamide (PX-2), and N-(1-amino-1-oxo-3-phenylpropan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide (PX-3) were investigated using human liver microsomes. Previous studies showed PX-3 as the most potent CB1 and CB2 receptor agonist.
Half-life and clearance data were acquired using liquid chromatography- tandem mass spectrometry. Metabolite elucidation was performed using liquid chromatography …
Targeting Lipoprotein Biogenesis: Considerations Towards Antimicrobials, Toufic El Arnaout, Tewfic Soulimane
Targeting Lipoprotein Biogenesis: Considerations Towards Antimicrobials, Toufic El Arnaout, Tewfic Soulimane
Articles
Decades have passed without approval of a new antibiotic class. Several companies have recently halted related discovery efforts because of multiple obstacles. One promising route under research is to target the lipoprotein maturation pathway in light of major recent findings and the virulence roles of lipoproteins. To support the future design of selective drugs, considerations and priority-setting are established for the main lipoprotein processing enzymes (Lgt, LspA, and Lnt) based on microbiology, biochemistry, structural biology, chemical design, and pharmacology. Although not all bacterial species will be similarly impacted by drug candidates, several advantages make LspA a top target to pursue …
Pharmacodynamics Of Monoamine Transporter Releasing Agents And Reuptake Inhibitors, Alexa Holloway
Pharmacodynamics Of Monoamine Transporter Releasing Agents And Reuptake Inhibitors, Alexa Holloway
Theses and Dissertations
Ligands of the human monoamine transporters encompass a wide range of both illicit and therapeutic drugs that act upon neural circuitry related to reward, motivation, and the processing of salient stimuli. The present study utilizes two methods for analyzing transporter substrates and inhibitors in order to characterize activity and assess potency. The first measures transient changes in intracellular calcium as a surrogate for transporter activity by harnessing the electrical coupling of monoamine transporters and L-type calcium channels. This is used to analyze novel chimera of the strong hDAT inhibitors methylphenidate and ��-PPP in order to assess the contribution of specific …